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Abstract
Background
Bariatric and metabolic surgery is used as a treatment for patients with severe and complex
obesity. However, there is a need to improve outcome selection and reporting in bariatric
surgery trials. A Core Outcome Set (COS), an agreed minimum set of outcomes reported in
all studies of a specific condition, may achieve this. Here, we present the development of a
COS for BARIAtric and metabolic surgery Clinical Trials—the BARIACT Study.
Methods and Findings
Outcomes identified from systematic reviews and patient interviews informed a question-
naire survey. Patients and health professionals were surveyed three times and asked to rate
the importance of each item on a 1–9 scale. Delphi methods provided anonymised feedback
to participants. Items not meeting predefined criteria were discarded between rounds.
Remaining items were discussed at consensus meetings, held separately with patients and
professionals, where the COS was agreed. Data sources identified 2,990 outcomes, which
were used to develop a 130-item questionnaire. Round 1 response rates were moderate but
subsequently improved to above 75% for other rounds. After rounds 2 and 3, 81 and 14
items were discarded, respectively, leaving 35 items for discussion at consensus meetings.
The final COS included nine items: “weight,” “diabetes status,” “cardiovascular risk,” “overall
quality of life (QOL),” “mortality,” “technical complications of the specific operation,” “any re-
operation/re-intervention,” “dysphagia/regurgitation,” and “micronutrient status.” The main
limitation of this study was that it was based in the United Kingdom only.
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Conclusions
The COS is recommended to be used as a minimum in all trials of bariatric and metabolic
surgery. Adoption of the COS will improve data synthesis and the value of research data.
Future work will establish methods for the measurement of the outcomes in the COS.
Introduction
The worldwide prevalence of obesity has more than doubled since 1980 and is associated with
an increased risk of comorbidities, such as type 2 diabetes, and premature death [1]. Surgery is
the most effective treatment for patients with severe and complex obesity (body mass index
40 or between 35 and 40 with another significant comorbidity that could be improved by
weight loss) [2–4]. Common operations undertaken include the Roux-en-Y gastric bypass, the
sleeve gastrectomy, and the adjustable gastric band [2,3,5]. Each have different risks and out-
come trajectories [2,3,6,7]. Understanding the relative differences between interventions needs
data from well-designed and conducted randomised controlled trials (RCTs) to inform deci-
sion-making. However, a Cochrane review found that trials were limited by a lack of consis-
tency in outcome reporting, which hampered cross-study comparison and meta-analysis [3].
This review called for the development of a Core Outcome Set (COS) to improve the consis-
tency of outcomes in future trials [3].
A COS is an agreed minimum set of outcomes to be measured and reported in all studies of
a particular disease or condition [8]. A COS is not meant to be restrictive, rather the minimum
that should be reported [9]. The uptake and use of a COS can help to reduce the heterogeneity
of outcomes reported across trials and reduce outcome reporting bias—the selective reporting
of some outcomes from those that were originally measured in a study, on the basis of their
results [8,10]. A COS can thus improve the quality of the data available to undertake meta-
analyses and inform clinical decision-making [11]. The aim of this study was to develop a COS
for bariatric and metabolic surgery, including outcomes relating to both the effectiveness and
the safety of the surgery (the BARIACT project) for use in future effectiveness trials.
Methods
Ethics Statement
Ethical approval from Southwest-Frenchay Research Ethics Committee (reference 11/SW/
0248) was obtained.
Development of the COS involved three phases: (1) the generation of a comprehensive list of
outcomes and a questionnaire; (2) a Delphi survey involving three rounds to gain consensus as to
which outcomes are most important; and (3) patient and professional consensus meetings to
agree a final COS. These phases are summarised in Fig 1 and as a table in the supporting informa-
tion (S1 Table). The project was registered with the COMET (Core Outcome Measures in Effec-
tiveness Trials) Initiative [12,13]. In reporting the development of this COS, we have adhered to
the COS-STAR (Core Outcome Set-STAndards for Reporting) Statement (S2 Table) [14].
Phase 1: Generation of a Comprehensive List of Outcomes and a
Questionnaire
A comprehensive list of outcomes of bariatric surgery was informed by literature reviews
including qualitative research studies [15–18]. These were supplemented with outcomes
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Fig 1. Summary of the development of a COS for bariatric and metabolic surgery.
doi:10.1371/journal.pmed.1002187.g001
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elicited from semi-structured interviews with patients [17,18]. All outcomes were indepen-
dently mapped into health domains by at least two researchers (including expert health profes-
sionals and methodologists) [19]. A health domain was defined as a broad class of outcome;
for example, the domain “obesity-related disease” included diabetes, hypertension, dyslipidae-
mia, cardiovascular risk, obstructive sleep apnoea, and joint disease. The final list of domains
and outcomes was used to develop a questionnaire, with each outcome forming an individual
item and domains forming section headings. Items were written in lay terms with medical
terms in brackets to optimise understanding. Further detail on the methodology for this phase
of the research has previously been reported [20].
Phase 2: Delphi Questionnaire Surveys
To ensure the resulting COS was patient-centred, both specialist health professionals involved
in the care of bariatric surgery patients and patients who had undergone bariatric surgery were
invited to participate in the consensus process. Health professionals (surgeons, nurses, dieti-
tians, psychologists, physicians, and anaesthetists) were identified through professional socie-
ties (the British Obesity and Metabolic Surgery Society, the Association of Physicians
Specialising in Obesity UK, The Society for Obesity and Bariatric Anaesthesia, the British Psy-
chological Society, and an informal list of bariatric clinical psychologists) and participation in
the By-Band-Sleeve Study (a pragmatic RCT comparing gastric bypass, gastric banding, and
sleeve gastrectomy) [21]. Individuals were invited to participate by post or email from their
Society and were sent an initial questionnaire. Patients who had undergone bariatric surgery
in the previous five years at two hospitals participating in the pilot phase of the By-Band-Sleeve
Study were purposively sampled (based on gender, type of surgery, and time since surgery)
and invited to participate. Patients returning a signed consent form were posted the question-
naire. Non-responding health professionals and patients providing consent but not returning
the questionnaire were sent one reminder. In the absence of agreed methodology to determine
a sample size for Delphi surveys, the target sample was 100 professionals and 100 patients
[22,23].
The Delphi process consisted of three sequential rounds of questionnaires with the same
group of participants. Those that completed a questionnaire in round 1 were eligible to partici-
pate in round 2, and those that completed round 2 were eligible to participate in round 3. In
each questionnaire, participants were asked to rate the importance of each item from 1 (not
important) to 9 (extremely important). Responses were summarised and fed back (anony-
mously) in subsequent rounds. Participants received their own scores, the median score of the
overall patient group, and the median score assigned by all health professionals for each item.
For professionals, scores were further broken down with the median scores presented for their
own peer group, other health professionals, and patients.
All items were retained between rounds 1 and 2. At the end of rounds 2 and 3, items were
only retained if they met prespecified criteria (see “Statistical Analyses” section). Further con-
sideration was given by the research team to whether any remaining items could be merged.
Items retained at the end of round 3 were considered at the consensus meetings.
Phase 3: Face-to-Face Consensus Meetings
Consensus meetings were held separately with patients and professionals to ensure that meet-
ings were not dominated by professionals’ views. Meetings were held in Bristol, UK in October
and November 2015. Participants completing all three questionnaires were invited to attend,
in addition to professional members of the By-Band-Sleeve Study group.
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Retained items and median scores for the patient and professional groups were presented
and participants asked to vote “Yes” (this item should be included in the COS), “No” (this item
should not be included), or “Unsure” using anonymised keypad voting [24]. Item wording was
shortened and simplified for the consensus meetings to allow for ease of reading on Microsoft
Powerpoint slides, with verbal clarification as needed. Item wording used for patient and pro-
fessional consensus meetings is provided as supporting information (S3 Table). Voting results
for each item were presented immediately in the form of a histogram. Items were retained or
dropped when consensus was reached (see “Statistical Analyses” section). Discussion and fur-
ther rounds of voting, restricting the options to “Yes” or “No,” were undertaken until consen-
sus was reached on all items. All items retained from both meetings were included in the final
COS.
Statistical Analyses
Analyses were undertaken using STATA 13 [25]. After each Delphi round the median score
for each item was calculated for patients and professionals and each professional sub-group;
median scores were presented as feedback in the subsequent round (round 3 presented in the
consensus meetings). For merged items, participants’ scores were calculated as the mean of the
individual items’ scores, and group scores were calculated as the mean of the individual items’
median scores.
At the end of rounds 2 and 3, the percentage of participants who rated each item 8 or 9 was
calculated, and items were retained if they were scored 8 or 9 by at least 70% of respondents.
These criteria were considered separately for patients and professionals, and items were
retained if they met these criteria. Items discussed at the consensus meetings were retained if
at least 70% of participants voted “Yes”; items were discarded if at least 70% voted “No.”
Results
Phase 1
The literature and interviews yielded 2,990 outcomes which were categorised into 17 domains,
forming a 130-item questionnaire [20].
Phase 2
Four hundred fifty-nine professionals were invited, of which 168 (36.6%) returned the ques-
tionnaire. The round 2 denominator was reduced to 157 due to the researchers being unable
to send questionnaires to 11 professionals (five had not provided contact details in round 1,
four were on maternity leave, and two had moved away). 76.4% (120/157) and 85.0% (102/
120) completed rounds 2 and 3, respectively. Participating health professionals included 81
(48.2%) surgeons, 33 (19.6%) dietitians, 24 (14.3%) specialist nurses, 12 (7.1%) bariatric physi-
cians, 10 (6.0%) psychologists, three (1.8%) anaesthetists, three (1.8%) GPs, one (0.6%) physio-
therapist, and one (0.6%) “other” health professional. The majority (160, 95.2%) of
professionals were from the UK, two were from the Republic of Ireland, one was from Bel-
gium, and five did not specify their country.
Of the 465 patients invited to participate, 112 (24.1%) consented. Of these, 90 (80.4%) com-
pleted the round 1 questionnaire (56 from centre 1 and 34 from centre 2). One patient with-
drew after round 1. 89.9% (80/89), and 88.8% (71/80) completed rounds 2 and 3, respectively.
Patients were 65.6% female and had a mean age of 54.4 years (standard deviation [SD] of 9.6
years). The majority (95.6%) were “White British.” Fifty-eight (64.4%) underwent a Roux-en-
Y gastric bypass, 21 (23.3%) an adjustable gastric band, six (6.7%) a sleeve gastrectomy, two
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(2.2%) more than one type of surgery, one (1.1%) “another” type of surgery, and two (2.2%)
were awaiting surgery. The mean time since surgery was 3.5 years (SD 2.1 years).
In round 1, 33 items were classed as “very important.” More details are available elsewhere
[20]. After providing feedback in round 2, 57 items were classed as “very important.” These
were retained for round 3, as well as six “borderline” items ( 65% of either patients or profes-
sionals rated these items 8–9), which had been highlighted as very important by patients in the
qualitative interviews, which informed the initial list of outcomes (Table 1). The remaining 67
items were not carried forward to round 3. Fourteen of the 63 retained items were merged
with other items, leading to 49 items on the round 3 questionnaire (Table 1). The rounds 2
and 3 professional and patient questionnaires are provided as supporting information (S1–S4
Questionnaire). The round 1 questionnaires are available elsewhere [20].
After round 3, 41 items were classed as “very important” by either group and were retained
for the meetings (Table 2). As 41 was a large number of items to vote on at a meeting, items
were scrutinised by the research team. Six were merged, reducing the number of items to 35
(Table 2). Three other items (“leaks, fistulas, strictures, and ulcerations at anastomosis,” “mor-
tality (30-day or long-term),” and “improvement in diabetes”) rated 8 or 9 by at least 90% of
either group were considered to be extremely important and therefore were not discussed fur-
ther but included in the COS. The merged item “weight” (including weight reduction/mainte-
nance) was also included in the final COS, being highlighted as very important by patients in
the qualitative interviews that informed the initial comprehensive list of outcomes. Thus, the
total number of items to be voted on at the consensus meetings was 31. The ratings of all ques-
tionnaire items for rounds 1, 2, and 3 are provided in the supporting information (S4 and S5
Tables).
Phase 3: Face-to-Face Consensus Meetings
Thirty-seven patients and 46 professionals indicated an interest in attending a consensus meet-
ing. Of these, eight patients and one partner attended the patient meeting. Five were female,
with a mean age of 55 years (SD 9.8 years). Seven had undergone a Roux-en-Y gastric bypass,
and one had undergone an adjustable gastric band. Their mean time since surgery was 4.3
years (SD 1.9 years).
Thirty-three professionals attended the professional meeting. This included 14 (42.4%) sur-
geons, 10 (30.3%) specialist nurses, four (12.1%) dietitians, three (9.1%) bariatric physicians,
one (3.0%) psychologist, and one (3.0%) “other” health professional. All except one attendee
(Australia) were from the UK.
At the consensus meetings, the four pre-agreed items were presented and the remaining 31
voted on. Tables 3 and 4 show the results of the voting and discussion.
After the initial round of anonymised voting at the patients’ meeting, six items were voted
“In,” three “Out,” and 22 “Unsure” (Table 3). At the professionals’ meeting, five were voted
“In,” seven “Out,” and 19 “Unsure” (Table 4). “Unsure” items underwent further discussion
and voting. Extensive discussion in meetings revealed that some items overlapped in content
and meaning. Thus, some were merged into a single item. For example, at the professionals’
meeting, the consensus was that the ten items relating to quality of life (QOL) (e.g., “mobility,”
“self-esteem and self-confidence”) should be combined into a single item, “overall quality of
life.” Professionals indicated that they would have liked to include all ten QOL items (which
would have meant 18 items in the final COS). However, they were aware of the importance of
limiting the final COS for it to be feasible to use in future trials. Therefore, the consensus was
to include one QOL item that would encompass all of the more specific items. Similarly, items
relating to potential complications of surgery were combined into two items, “technical
PLOS Medicine | DOI:10.1371/journal.pmed.1002187 November 29, 2016 6 / 17
Table 1. Items retained for round 3.
% rating item 8–9 in round 2
Item details (n = 63) Patients (n = 80) HCPs (n = 120)
1 Intra-operative organ injury 78.8 62.2
2 Intra-abdominal abscess 76.3 68.1
3 Wound infection or dehiscence 71.3 35.3
4 Septicaemia 87.5 85.7
5 Gastro-intestinal bleedinga 72.2 67.8
6 Intra-abdominal bleedinga 71.3 78.2
7 Staple line bleeda 78.8 77.3
8 Gastric fistulab 86.1 89.0
9 Anastomotic leakb 91.3 92.4
10 Bowel stricture 80.0 79.7
11 Anastomotic ulceration 76.3 67.2
12 Band infectionc 78.7 84.9
13 Band erosionc 84.0 94.9
14 Band revisionsc 74.7 78.8
15 Port revisionsd 70.7 61.3
16 Port infectiond 73.3 67.2
17 Port malfunctiond 73.3 41.5
18 Band slippage 82.7 94.9
19 Internal hernia 78.5 89.8
20 Adhesional obstruction 71.8 49.2
21 Requirement for ventilation 73.4 62.7
22 Ischaemic/coronary heart diseasee 77.2 41.5
23 Arrhythmiae 71.8 21.2
24 Venous thromboembolism 84.8 79.7
25 Cerebrovascular accident 83.5 57.6
26 Renal failure 81.0 49.2
27 Perioperative mortalityf 92.4 94.9
28 In hospital mortalityf 91.1 96.6
29 30-day mortalityf 91.1 94.8
30 >30-day mortality 87.3 89.7
31 Dysphagia/regurgitation 65.8 73.3
32 Vitamin levelsg 67.1 85.8
33 Mineral levelsg 55.7 80.8
34 Readmission rates 64.6 79.2
35 Weighth 62.0 92.4
36 Body mass indexh 53.2 86.4
37 Hypertension 87.5 84.7
38 Cardiovascular risk 88.8 77.1
39 Diabetes 92.5 98.3
40 Dyslipidaemia 70.9 85.6
41 Obstructive sleep apnoea 84.8 90.8
42 Joint disease 86.8 72.9
43 Being able to carry out usual activities 73.4 81.7
44 Mobility 82.3 78.3
45 Fitness 73.4 45.8
46 Being able to accomplish work tasks, or to take up work 75.9 82.5
(Continued )
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complications of the specific operation” and “any re-operation/re-intervention and its classifi-
cation of severity.” After voting and discussion, an additional six items were included by
patients and four items by professionals. Thus, the final COSs agreed by patients and profes-
sionals included 12 and nine items, respectively (Table 5). When comparing COSs, all 12 items
included in the patient COS were represented in the health professional COS, as professionals
merged four items included by patients as “overall quality of life.” The only item included by
health professionals that was not included by patients was “cardiovascular risk.” Thus, the final
COS includes nine items (Table 5).
Discussion
This study has developed a COS to use in studies of bariatric and metabolic surgery. A wide
range of sources, including the literature and patient interviews, were used to inform a prioriti-
sation exercise. This was undertaken with over 250 health professionals and patients to identify
the outcomes of greatest importance. The final core set consists of nine outcomes important to
Table 1. (Continued)
% rating item 8–9 in round 2
Item details (n = 63) Patients (n = 80) HCPs (n = 120)
47 Feeling in control of weight and appearance 77.2 59.7
48 Excess skin or skin folds following weight loss* 69.6 52.1
49 Having a healthy/balanced eating pattern 77.2 73.9
50 Being able to stop eating when feeling full 81.0 72.3
51 Feeling satisfied and confident with one’s bodyi 70.9 59.7
52 Self-esteem and self-confidencei 73.4 58.8
53 Depression 69.6 70.6
54 Anxiety* 65.8 66.4
55 Suicidal thoughts 64.6 73.9
56 Other addictive behaviours* 58.2 68.9
57 Overall quality of sleep 77.2 47.9
58 Relationship with partner/spousej* 61.0 45.0
59 Relationship with childrenj* 67.9 54.2
60 Relationship with friendsj* 44.3 22.5
61 Feeling able to live a “normal” life 81.0 71.7
62 Feeling in control of health and well-being 79.7 63.0
63 Having a positive outlook on life and expectations for the future 84.8 65.8
HCPs = Healthcare professionals.
Items with superscripts a-j were merged to create the following single items for round 3.
a
“Intra-abdominal bleeding/gastrointestinal bleeding/staple line bleed.”
b
“Anastomotic leak/gastric fistula.”
c
“Band infection, erosion, and revisions.”
d
“Port malfunction/revisions/infection.”
e
“Angina/myocardial infarction/arrhythmia.”
f
“Death (during the operation or within 30 days of surgery).”
g
“Micronutrient levels.”
h Items merged and used to create two new items, “reduction in weight” and “maintaining weight loss/preventing weight re-gain.”
i
“Self-esteem and self-confidence.”
j
“Relationship with partner/spouse, friends, and/or ability to care for children.”
* Borderline items (at least 65% of either patients or health professionals rated these items 8–9 in round 2) kept in for round 3.
doi:10.1371/journal.pmed.1002187.t001
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Table 2. Items brought forward to the consensus meetings.
% rating item 8–9 in round 3
Item details (n = 41) Patients
(n = 71)
HCPs
(n = 102)
Intra-operative organ injury 77.5 55.9
Intra-abdominal abscess 78.9 61.8
Septicaemia 88.7 82.4
Bleeding problems—includes intra-abdominal, gastrointestinal, and staple
line bleeding
80.3 78.4
Anastomotic leak/gastric fistulaa* 91.6 90.2
Bowel stricturea* 83.1 67.7
Anastomotic ulcerationa* 78.9 52.9
Band infection, erosion, and revisionsb 84.4 84.3
Band slippageb 85.9 88.1
Port problems 79.7 58.8
Internal hernia 82.9 81.4
Needing to go to intensive care unit for ventilation 73.2 48.5
Cardiac problems due to surgery 71.8 31.7
Venous thromboembolism 83.1 77.2
Stroke 84.5 59.4
Renal failure 77.5 37.6
30-day mortalityc* 90.1 94.1
>30-day mortalityc* 90.1 86.3
Dysphagia/regurgitation 70.4 57.8
Problems with micronutrient levels 70.4 67.7
Readmission rates 73.2 72.6
Reduction in weightd* 78.6 88.1
Maintaining weight loss/preventing weight re-gaind* 87.1 89.1
Feeling in control of weight and appearanced* 77.5 50.0
Reduction in hypertension 81.4 74.3
Reduction in cardiovascular risk 84.3 70.0
Improvement in diabetes* 87.1 96.0
Reduction in dyslipidaemia 72.9 64.0
Reduction in obstructive sleep apnoea 84.3 77.2
Improvement in joint disease 81.4 61.0
Ability to carry out usual activities 81.7 67.7
Improved mobility 87.3 75.5
Ability to accomplish work tasks, or to take up work 71.8 66.7
Having a healthy/balanced eating pattern 73.2 63.7
Ability to stop eating when feeling full 83.1 59.8
Improved self-esteem and self-confidence 83.1 68.3
Improvement in depression 74.7 58.4
Reduction in anxiety 73.2 48.5
Feeling able to live a “normal” life 84.3 65.7
Feeling in control of health and well-being 84.5 60.8
Having a positive outlook on life and expectations for the future 87.3 55.9
HCPs = Healthcare professionals.
a Merged to create one item, “Leaks, fistulas, strictures, and ulcerations at anastomosis.”
b Merged to create one item, “Gastric band problems.”
c Merged to create one item, “Mortality (30-day or long-term).”
d Merged to create one item, “Weight.”
* Included as a definite in the final COS and not voted on at consensus meetings.
doi:10.1371/journal.pmed.1002187.t002
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Table 3. Results of the patient consensus meeting.
Number of patients
(out of 8) voting (%)
Item Item In Unsure Item Out Initial views Final decision
Diabetes status Definitely in COS—not voted on Retain item
Mortality (30-day or long-term) Definitely in COS—not voted on Retain item
Leaks, fistulas, strictures, and
ulcerations at anastomosis
Definitely in COS—not voted on Retain “leaks, fistulas, strictures, and
ulcers at anastomosis/gastric band
problems”a
Weight Definitely in COS—not voted on Retain item
Hypertension 3 (37.5) 2 (25.0) 3 (37.5) Unsure Voted out
Cardiovascular risk 4 (50.0) 1 (12.5) 3 (37.5) Unsure Voted out
Dyslipidaemia 0 (0.0) 1 (12.5) 7 (87.5) Out Voted out
Obstructive sleep apnoea 1 (12.5) 0 (0.0) 7 (87.5) Out Voted out
Joint disease 3 (37.5) 3 (37.5) 2 (25.0) Unsure Voted out
Ability to carry out usual activities 5 (62.5) 1 (12.5) 2 (25.0) Unsure Retain “mobility/ability to carry out
usual activities/living a normal life”a
Mobility 6 (75.0) 1 (12.5) 1 (12.5) In Retain “mobility/ability to carry out
usual activities/living a normal life”a
Ability to do your work, or to take up
work
6 (75.0) 1 (12.5) 1 (12.5) In Retain item
Having a healthy/balanced eating
pattern
5 (62.5) 0 (0.0) 3 (37.5) Unsure Retain “feeling in control”a
Ability to stop eating when feeling full 2 (25.0) 3 (37.5) 3 (37.5) Unsure Retain “feeling in control”a
Self-esteem and self-confidence 7 (87.5) 0 (0.0) 1 (12.5) In Retain “self-esteem and self-
confidence/depression/having a
positive outlook on life and
expectations for the future”a
Depression 2 (25.0) 2 (25.0) 4 (50.0) Unsure Retain “self-esteem and self-
confidence/depression/having a
positive outlook on life and
expectations for the future”a
Anxiety 0 (0.0) 2 (25.0) 6 (75.0) Out Voted out
Feeling able to live a “normal” life 5 (62.5) 2 (25.0) 1 (12.5) Unsure Retain “mobility/ability to carry out
usual activities/living a normal life”a
Feeling in control of health and well-
being
5 (62.5) 3 (37.5) 0 (0.0) Unsure Retain “feeling in control”a
Having a positive outlook on life and
expectations for the future
5 (62.5) 0 (0.0) 3 (37.5) Unsure Retain “self-esteem and self-
confidence/depression/having a
positive outlook on life and
expectations for the future”a
Intra-operative organ injury 6 (75.0) 1 (12.5) 1 (12.5) In Retain item
Intra-abdominal abscess 2 (25.0) 4 (50.0) 2 (25.0) Unsure Voted out
Septicaemia 5 (62.5) 2 (25.0) 1 (12.5) Unsure Voted out
Bleeding problems—includes intra-
abdominal, gastrointestinal, and staple
line bleeding
3 (37.5) 2 (25.0) 3 (37.5) Unsure Voted out
Gastric band problems 3 (37.5) 3 (37.5) 2 (25.0) Unsure Retain “leaks, fistulas, strictures, and
ulcers at anastomosis/gastric band
problems”a
Port problems 1 (12.5) 5 (62.5) 2 (25.0) Unsure Retain “leaks, fistulas, strictures, and
ulcers at anastomosis/gastric band
problems”a
Internal hernia 7 (87.5) 1 (12.5) 0 (0.0) In Retain item
Needing to go to ITU for ventilation 1 (12.5) 3 (37.5) 4 (50.0) Unsure Voted out
(Continued )
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different professionals and patients, including weight, diabetes, cardiovascular risk, QOL, and
potential risks of the surgery. It is now recommended that researchers use the COS to inform
the selection of measures used in future studies evaluating bariatric surgery.
To our knowledge, this is the first study to develop a COS for bariatric surgery including pro-
fessionals’ and patients’ views. The authors of the Cochrane review of bariatric surgery noted
particular problems with the heterogeneity of surgical complications reported across studies
and specified that mortality and re-operation rates should be reported in all future studies [3].
The authors suspected that outcome reporting bias was particularly a problem for QOL and dia-
betes outcomes [3]. Therefore, it may be particularly important that these form part of the mini-
mum COS. The COS developed in this study included the outcomes “diabetes status,” “overall
quality of life,” “mortality (30-day and/or long-term),” “any re-operation/re-intervention and
its classification of severity,” and thus includes all outcomes specified in the Cochrane review.
In 2004, a COS for obesity in general was published based on the International Classifica-
tion of Functioning, Disability, and Health (ICF) checklist [26]. This was developed from pre-
liminary work to develop a COS for chronic conditions in general, which included systematic
reviews, a Delphi survey of health professionals working with patients with chronic conditions,
and the administration (by health professionals) of the ICF checklist to patients with a range of
chronic conditions [27–29]. The COS for obesity was then finalised in a consensus meeting
with health professionals working in obesity and included nine items: “energy and drive,”
“weight maintenance,” “general metabolic functions,” “handling stress and other psychological
demands,” “walking,” “moving around,” “looking after one’s health,” “products or substances
for personal consumption,” and “immediate family” [26]. The COS developed by Stucki et al.
is not specific for different obesity treatments, like bariatric surgery. In comparison with our
COS, the item “overall quality of life” may encompass the majority of items in their brief COS.
An additional issue with the obesity COS proposed by Stucki et al. is the lack of patient input,
and participating professionals were mainly physicians, with limited numbers of other health
professionals [26,27]. The main reasons for including patients’ views are to ensure that benefits
as well as risks of surgery are included and to keep outcomes patient centred and relevant to
pragmatic trials and health services provision [30].
This study is novel and was conducted using appropriate methodology with key stakehold-
ers, including patients, to develop a COS for bariatric surgery. However, there are some meth-
odological limitations. There were low response rates to round 1 of the Delphi survey, which
Table 3. (Continued)
Number of patients
(out of 8) voting (%)
Item Item In Unsure Item Out Initial views Final decision
Cardiac problems due to surgery 4 (50.0) 0 (0.0) 4 (50.0) Unsure Voted out
Venous thromboembolism due to
surgery
4 (50.0) 0 (0.0) 4 (50.0) Unsure Voted out
Stroke due to surgery 3 (37.5) 2 (25.0) 3 (37.5) Unsure Voted out
Renal failure due to surgery 5 (62.5) 2 (25.0) 1 (12.5) Unsure Voted out
Dysphagia/regurgitation 6 (75.0) 0 (0.0) 2 (25.0) In Retain item
Micronutrient status 5 (62.5) 3 (37.5) 0 (0.0) Unsure Retain item
Readmission rates 5 (62.5) 1 (12.5) 2 (25.0) Unsure Voted out
ITU = Intensive Treatment Unit.
a Item retained and merged with at least two other items.
doi:10.1371/journal.pmed.1002187.t003
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Table 4. Results of the health professional consensus meeting.
Number of professionals
(out of 33) voting (%)
Item Item In Unsure Item Out Initial views Final decision
Diabetes status Definitely in COS—not voted on Retain item
Mortality (30-day or long-term) Definitely in COS—not voted on Retain item
Leaks, fistulas, strictures, and
ulcerations at anastomosis
Definitely in COS—not voted on Retain “technical complications of the
specific operation” and “any re-
operation/re-intervention and its
classification of severity”a
Weight Definitely in COS—not voted on Retain item
Hypertension 17 (51.5) 4 (12.1) 12 (36.4) Unsure Voted out
Cardiovascular risk 23 (69.7) 2 (6.1) 8 (24.2) In Retain item
Dyslipidaemia 7 (21.2) 5 (15.2) 21 (63.6) Unsure Voted out
Obstructive sleep apnoea 16 (48.5) 3 (9.1) 14 (42.4) Unsure Voted out
Joint disease 6 (18.2) 2 (6.1) 25 (75.8) Out Voted out
Ability to carry out usual activities 14 (42.4) 1 (3.0) 18 (54.5) Unsure Retain “overall quality of life”a
Mobility 24 (72.7) 2 (6.1) 7 (21.2) In Retain “overall quality of life”a
Ability to do your work, or to take up
work
13 (39.4) 4 (12.1) 16 (48.5) Unsure Retain “overall quality of life”a
Having a healthy / balanced eating
pattern
11 (33.3) 3 (9.1) 19 (57.6) Unsure Retain “overall quality of life”a
Ability to stop eating when feeling full 11 (33.3) 3 (9.1) 19 (57.6) Unsure Retain “overall quality of life”a
Self-esteem and self-confidence 15 (45.5) 6 (18.2) 12 (36.4) Unsure Retain “overall quality of life”a
Depression 10 (30.3) 3 (9.1) 20 (60.6) Unsure Retain “overall quality of life”a
Anxiety 1 (3.0) 2 (6.1) 30 (90.9) Out Retain “overall quality of life”a
Feeling able to live a “normal” life 12 (36.4) 6 (18.2) 15 (45.5) Unsure Retain “overall quality of life”a
Feeling in control of health and well-
being
13 (39.4) 3 (9.1) 17 (51.5) Unsure Retain “overall quality of life”a
Having a positive outlook on life and
expectations for the future
8 (24.2) 3 (9.1) 22 (66.7) Unsure Retain “overall quality of life”a
Intra-operative organ injury 3 (9.1) 2 (6.1) 28 (84.8) Out Retain “technical complications of the
specific operation” and “any re-
operation/re-intervention and its
classification of severity”a
Intra-abdominal abscess 6 (18.2) 3 (9.1) 24 (72.7) Out Retain “technical complications of the
specific operation” and “any re-
operation/re-intervention and its
classification of severity”a
Septicaemia 10 (30.3) 2 (6.1) 21 (63.6) Unsure Retain “any re-operation/re-intervention
and its classification of severity”a
Bleeding problems—includes intra-
abdominal, gastrointestinal and staple
line bleeding
17 (51.5) 2 (6.1) 14 (42.4) Unsure Retain “technical complications of the
specific operation” and “any re-
operation/re-intervention and its
classification of severity”a
Gastric band problems 22 (66.7) 3 (9.1) 8 (24.2) Unsure Retain “technical complications of the
specific operation” and “any re-
operation/re-intervention and its
classification of severity”a
Port problems 11 (33.3) 1 (3.0) 21 (63.6) Unsure Retain “technical complications of the
specific operation” and “any re-
operation/re-intervention and its
classification of severity”a
Internal hernia 20 (60.6) 0 (0.0) 13 (39.4) Unsure Retain “technical complications of the
specific operation” and “any re-
operation/re-intervention and its
classification of severity”a
(Continued)
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suggests that the use of questionnaires may not have appealed to all stakeholders. However, the
use of a Delphi survey was felt to be the most appropriate method, as it allowed a much larger
number of professionals and patients to participate than purely face-to-face methods would
have, and retention rates in rounds 2 and 3 of the survey were good. A maximum variation
sampling strategy was used to ensure that all predefined stakeholder groups were sampled and
Table 4. (Continued)
Number of professionals
(out of 33) voting (%)
Item Item In Unsure Item Out Initial views Final decision
Needing to go to ITU for ventilation 8 (24.2) 3 (9.1) 22 (66.7) Unsure Retain “any re-operation/re-intervention
and its classification of severity”a
Cardiac problems due to surgery 4 (12.1) 2 (6.1) 27 (81.8) Out Retain “any re-operation/re-intervention
and its classification of severity”a
Venous thromboembolism due to
surgery
15 (45.5) 2 (6.1) 16 (48.5) Unsure Retain “any re-operation/re-intervention
and its classification of severity”a
Stroke due to surgery 2 (6.1) 2 (6.1) 29 (87.9) Out Retain “any re-operation/re-intervention
and its classification of severity”a
Renal failure due to surgery 2 (6.1) 1 (3.0) 30 (90.9) Out Retain “any re-operation/re-intervention
and its classification of severity”a
Dysphagia/regurgitation 26 (78.8) 0 (0.0) 7 (21.2) In Retain item
Micronutrient status 27 (81.8) 0 (0.0) 6 (18.2) In Retain item
Readmission rates 24 (72.7) 2 (6.1) 7 (21.2) In Retain “any re-operation/re-intervention
and its classification of severity”a
ITU = Intensive Treatment Unit.
a Item retained and merged with at least two other items.
doi:10.1371/journal.pmed.1002187.t004
Table 5. Comparison of health professional and patient final COSs.
Health professional COSa Equivalent items included in patient COS
1 Weight 1 Weight
2 Diabetes status 2 Diabetes status
3 Cardiovascular risk Not included by patients
4 Overall quality of life 3–6 Mobility/ability to carry out usual activities/living a normal
life
Ability to do your work, or to take up work
Feeling in control
Self-esteem and self-confidence/depression/having a
positive outlook on life and expectations for the future
5 Mortality (30-day or long-term) 7 Mortality (30-day or long-term)
6 Technical complications of the
specific operation
8–
10
Leaks, fistulas, strictures, and ulcers at anastomosis/
gastric band problems
Intra-operative organ injury
Internal hernia
7 Any re-operation/re-intervention and
its classification of severity
8, 10 Leaks, fistulas, strictures, and ulcers at anastomosis/
gastric band problems
Internal hernia
8 Dysphagia/regurgitation 11 Dysphagia/regurgitation
9 Micronutrient status 12 Micronutrient status
a The final COS, as it also includes all the items in the patient COS.
Items 1–4 relate to potential benefits of the surgery, and 5–9 relate to potential complications of the surgery.
doi:10.1371/journal.pmed.1002187.t005
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representative of patients undergoing surgery and relevant health professionals. It was a
strength that our patient participants had a mean time since surgery of 3.5 years, as they had
experience of living with the outcomes of surgery in the long term after the initial “honey-
moon” phase had worn off [31]. We recognise that eight patients was a low number of partici-
pants in the consensus meeting. However, their views about which outcomes to include in the
COS were supported by the professionals’ views, as well as our own experience of issues raised
by patients in clinical practice. “Cardiovascular risk” is the only outcome in the COS that was
included by professionals but not patients. It may be that the future “risk” of cardiovascular
problems was not something patients could easily conceptualise; however, it was more of a pri-
ority for professionals who regularly see patients with cardiovascular complications. The main
limitation of this study was that it was based only in the UK, although a few professionals from
other countries participated.
One next essential step is to undertake validation of the COS internationally and/or develop
the core outcome measures working with the international community. This could involve
undertaking consensus meetings with professionals and patients in other countries. The
OMERACT (Outcome Measures in Rheumatology) group have published guidance on the
selection of appropriate measures for COSs [32]. Further consensus methods will determine
how technical complications of the specific operations and re-operations/re-interventions
should be defined, as well as the key components of QOL. Literature reviews will be under-
taken to generate a list of available measurement instruments, and some instruments may
need to be developed where none are available. Where more than one instrument already
exists, the COSMIN (COnsensus-based Standards for the selection of health Measurement
INstruments) checklist may help with the selection of the most appropriate instrument [33].
This additional work will be crucial for the COS to gain widespread acceptance and use.
This study has used high-quality methods to develop a COS for studies evaluating bariatric
and metabolic surgery. Its widespread adoption by the bariatric surgery community will
improve the quality of outcome data from research studies, thus improving meta-analyses and
the value of the research to clinical practice. Future work is needed to validate the COS inter-
nationally and determine how these outcomes are best measured.
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